Lymphoblastic Leukemia, Acute T-cell
2 clinical trials · Condition
◉ Watch Lymphoblastic Leukemia, Acute T-cell
| Record | Firm | Date |
|---|---|---|
| BCL-2 Inhibitors Combined with the HyperCVAD Regimen for Newly Diagnosed T-lymphoblastic Leukemia/lymphoma. (NCT06598722) | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 2024-08-07 |
| Study to Evaluate the Safety and Tolerability of Weekly Intravenous (IV) Doses of BMS-906024 in Subjects With Acute T-cell Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma (NCT01363817) | Bristol-Myers Squibb | 2011-09-28 |
Track Lymphoblastic Leukemia, Acute T-cell automatically
Every clearance here is in the API, with alerts when new ones post.